CYSLTR1 and renal carcinoma: RCC also demonstrates upregulation of ALOX5, TBXAS1, and cysLTR1, supporting literature on the role of TBXA2 in upregulating renal cancer and 5-LOX in progressing carcinogenesis [32,33].